[1]Taniyamaetal.[YakugakuZasshi/JournalofthePharmaceuticalSocietyofJapan,1954,vol.74,p.374,378][Chem.Abstr.,1955,p.5442]
[1]CurrentPatentAssignee:CIBAPHARMACEUTICALPRODUCTS,INC.-US2672463,1951,A
[1]Puetzeretal.[JournaloftheAmericanChemicalSociety,1951,vol.73,p.2958]Das;Mukherjee[JournaloftheAmericanChemicalSociety,1953,vol.75,p.1241]
[1]Amal;Egernc[IstanbulUniversitesiFenFakultesiMecmuasi,1958,vol.<C>23,p.38,40]
[1]Bernsteinetal.[JournaloftheAmericanChemicalSociety,1951,vol.73,p.906,908]Eckensteinetal.[HelveticaChimicaActa,1950,vol.33,p.1353,1360]Maffiietal.[Farmaco,EdizioneScientifica,1958,vol.13,p.187,196]Medowschtschikowa;Postowskii[ZhurnalObshcheiKhimii,1954,vol.24,p.2024,2026;engl.Ausg.S.1989]
Title: A common mechanism of inhibition of the Mycobacterium tuberculosis mycolic acid biosynthetic pathway by isoxyl and thiacetazone.
Journal: The Journal of biological chemistry 20121109
Title: Mutations in the essential FAS II β-hydroxyacyl ACP dehydratase complex confer resistance to thiacetazone in Mycobacterium tuberculosis and Mycobacterium kansasii.
Journal: Molecular microbiology 20121101
Title: Exposure of mycobacteria to cell wall-inhibitory drugs decreases production of arabinoglycerolipid related to Mycolyl-arabinogalactan-peptidoglycan metabolism.
Journal: The Journal of biological chemistry 20120330
Title: Preclinical pharmacokinetics of KBF611, a new antituberculosis agent in mice and rabbits, and comparison with thiacetazone.
Journal: Xenobiotica; the fate of foreign compounds in biological systems 20100301
Title: Simultaneous determination of a new antituberculosis agent KBF-611 and its de-acetylated metabolite in mouse and rabbit plasma by HPLC.
Journal: Archives of pharmacal research 20091001
Title: Synthesis, activity, and pharmacophore development for isatin-beta-thiosemicarbazones with selective activity toward multidrug-resistant cells.
Journal: Journal of medicinal chemistry 20090528
Title: Mycolic acid methyltransferase, MmaA4, is necessary for thiacetazone susceptibility in Mycobacterium tuberculosis.
Journal: Molecular microbiology 20090301
Title: Human flavin-containing monooxygenase 2.1 catalyzes oxygenation of the antitubercular drugs thiacetazone and ethionamide.
Journal: Drug metabolism and disposition: the biological fate of chemicals 20090101
Title: In silico fasciolicide activity of three experimental compounds in sheep.
Journal: Annals of the New York Academy of Sciences 20081201
Title: Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Journal: Journal of medicinal chemistry 20081113
Title: EthA, a common activator of thiocarbamide-containing drugs acting on different mycobacterial targets.
Journal: Antimicrobial agents and chemotherapy 20070301
Title: The lipophilicity estimation of 5-arylidene derivatives of (2-thio)hydantoin with antimycobacterial activity.
Journal: Biomedical chromatography : BMC 20070301
Title: [A case of multidrug-resistant pulmonary tuberculosis cured by the regimen including thiacetazone].
Journal: Kekkaku : [Tuberculosis] 20070101
Title: Haemorheological variables in Nigeria pulmonary tuberculosis patients undergoing therapy.
Journal: Clinical hemorheology and microcirculation 20070101
Title: Thiacetazone, an antitubercular drug that inhibits cyclopropanation of cell wall mycolic acids in mycobacteria.
Journal: PloS one 20070101
Title: Extension of the intensive phase reduces unfavourable outcomes with the 8-month thioacetazone regimen.
Journal: The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 20061101
Title: Oxidative activation of thiacetazone by the Mycobacterium tuberculosis flavin monooxygenase EtaA and human FMO1 and FMO3.
Journal: Chemical research in toxicology 20060301
Title: [The rates of resistance to second-line drugs in multidrug resistant Mycobacterium tuberculosis strains].
Journal: Mikrobiyoloji bulteni 20060101
Title: Tuberculosis in people with HIV.
Journal: Clinical evidence 20051201
Title: Differential antibiotic susceptibilities of starved Mycobacterium tuberculosis isolates.
Journal: Antimicrobial agents and chemotherapy 20051101
Title: SRI-286, a thiosemicarbazole, in combination with mefloquine and moxifloxacin for treatment of murine Mycobacterium avium complex disease.
Journal: Antimicrobial agents and chemotherapy 20040901
Title: Thiosemicarbazole (thiacetazone-like) compound with activity against Mycobacterium avium in mice.
Journal: Antimicrobial agents and chemotherapy 20030801
Title: Drug resistance in tuberculosis in Delhi: a 2 year profile (2001--2002).
Journal: The Journal of communicable diseases 20030601
Title: Clinical concentrations of thioridazine kill intracellular multidrug-resistant Mycobacterium tuberculosis.
Journal: Antimicrobial agents and chemotherapy 20030301
Title: Activities of moxifloxacin alone and in combination with other antimicrobial agents against multidrug-resistant Mycobacterium tuberculosis infection in BALB/c mice.
Journal: Antimicrobial agents and chemotherapy 20030101
Title: In vitro activity of thiacetazone on mycobacterial species belonging to the Mycobacterium tuberculosis complex.
Journal: The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 20021001
Title: [Lyell syndrome in Senegal: responsibility of thiacetazone].
Journal: Annales de dermatologie et de venereologie 20011201
Title: [Multiresistant tuberculosis caused by Mycobacterium bovis and human immunodeficiency virus infection. Are there new therapeutic possibilities?].
Journal: Enfermedades infecciosas y microbiologia clinica 20010101
Title: Tuberculosis treatment: dangerous regimens?
Journal: The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 20010101
Title: Pattern of some haematological indices in newly diagnosed pulmonary tuberculosis cases in Iwo, Nigeria: diagnostic and therapeutic implications.
Journal: Nigerian journal of medicine : journal of the National Association of Resident Doctors of Nigeria 20010101
Title: [Skin toxicity of thiacetazone (TB1) at a hospital service in Dakar].
Journal: Dakar medical 20010101
Title: Use of genomics and combinatorial chemistry in the development of new antimycobacterial drugs.
Journal: Biochemical pharmacology 20000201
Title: Green fluorescent protein reporter microplate assay for high-throughput screening of compounds against Mycobacterium tuberculosis.
Journal: Antimicrobial agents and chemotherapy 19980201
Title: Microplate alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium.
Journal: Antimicrobial agents and chemotherapy 19970501
Title: Antituberculosis activity of clarithromycin.
Journal: Antimicrobial agents and chemotherapy 19951201
Title: The Garrod Lecture. Understanding the chemotherapy of tuberculosis--current problems.
Journal: The Journal of antimicrobial chemotherapy 19920501
Title: Thiacetazone: in vitro activity against Mycobacterium avium and M. tuberculosis.
Journal: Tubercle 19901201
Title: Electrophysiological evidence of peripheral nerve damage in patients treated with isoniazid.
Journal: East African medical journal 19821201
Title: Aplastic anaemia associated with anti-tuberculosis chemotherapy.
Journal: Acta haematologica 19820101
Title: The early bactericidal activity of drugs in patients with pulmonary tuberculosis.
Journal: The American review of respiratory disease 19800601
Title: Protein synthesis in Mycobacterium tuberculosis H37Rv and the effect of streptomycin in streptomycin-susceptible and -resistant strains.
Journal: Antimicrobial agents and chemotherapy 19730901
Title: Antibacterial nitrofuran derivatives. I. 5-nitro-2-furaldehyde semicarbazones and thiosemicarbazones.
Journal: Journal of medicinal chemistry 19670701
Title: The chemical approach to the control of tuberculosis.
Journal: Science (New York, N.Y.) 19520808
Title: J L Stigliani, et al. New Insights Into the Chemical Behavior of S-oxide Derivatives of Thiocarbonyl-Containing Antitubercular Drugs and the Influence on Their Mechanisms of Action and Toxicity. Ann Pharm Fr. 2019 Mar;77(2):126-135.
Title: P Khanna, et al. Characteristics of a Cytosolic Arylacylamidase Metabolizing Thiacetazone. J Pharmacol Exp Ther. 1992 Sep;262(3):1225-31.
Title: Anuradha Alahari, et al. Thiacetazone, an Antitubercular Drug That Inhibits Cyclopropanation of Cell Wall Mycolic Acids in Mycobacteria. PLoS One. 2007 Dec 19;2(12):e1343.
Title: C A Peloquin, et al. Pharmacokinetic Evaluation of Thiacetazone. Pharmacotherapy. Sep-Oct 1996;16(5):735-41.
